These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8403559)

  • 1. Prevention of runting and cachexia by a chimeric TNF receptor-Fc protein.
    Teng MN; Turksen K; Jacobs CA; Fuchs E; Schreiber H
    Clin Immunol Immunopathol; 1993 Nov; 69(2):215-22. PubMed ID: 8403559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group.
    Fisher CJ; Agosti JM; Opal SM; Lowry SF; Balk RA; Sadoff JC; Abraham E; Schein RM; Benjamin E
    N Engl J Med; 1996 Jun; 334(26):1697-702. PubMed ID: 8637514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumors secreting human TNF/cachectin induce cachexia in mice.
    Oliff A; Defeo-Jones D; Boyer M; Martinez D; Kiefer D; Vuocolo G; Wolfe A; Socher SH
    Cell; 1987 Aug; 50(4):555-63. PubMed ID: 3607879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of cachexia-like syndrome development and reduction of tumor progression in inhibin-deficient mice following administration of a chimeric activin receptor type II-murine Fc protein.
    Li Q; Kumar R; Underwood K; O'Connor AE; Loveland KL; Seehra JS; Matzuk MM
    Mol Hum Reprod; 2007 Sep; 13(9):675-83. PubMed ID: 17704537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The roles of gamma-interferon and tumor necrosis factor alpha in an experimental rat model of cancer cachexia.
    Langstein HN; Doherty GM; Fraker DL; Buresh CM; Norton JA
    Cancer Res; 1991 May; 51(9):2302-6. PubMed ID: 1901758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term protection against the effects of tumour necrosis factor by controlled delivery of the soluble p55 TNF receptor.
    Eliaz R; Wallach D; Kost J
    Cytokine; 1996 Jun; 8(6):482-7. PubMed ID: 8818545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective up-regulation of tumor necrosis factor receptor I in tumor-bearing rats with cancer-related cachexia.
    Catalano MG; Fortunati N; Arena K; Costelli P; Aragno M; Danni O; Boccuzzi G
    Int J Oncol; 2003 Aug; 23(2):429-36. PubMed ID: 12851692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with tumor necrosis factor alpha and interferon alpha of a human kidney cancer xenograft in nude mice: evidence for an anticachectic effect of interferon alpha.
    Bassukas ID; Hofmockel G; Maurer-Schultze B
    Anticancer Res; 1994; 14(1A):237-45. PubMed ID: 8166454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of endogenous tumor necrosis factor alpha and interleukin 1 for experimental tumor growth and the development of cancer cachexia.
    Gelin J; Moldawer LL; Lönnroth C; Sherry B; Chizzonite R; Lundholm K
    Cancer Res; 1991 Jan; 51(1):415-21. PubMed ID: 1703040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term inhibition of tumor growth by tumor necrosis factor in the absence of cachexia or T-cell immunity.
    Teng MN; Park BH; Koeppen HK; Tracey KJ; Fendly BM; Schreiber H
    Proc Natl Acad Sci U S A; 1991 May; 88(9):3535-9. PubMed ID: 2023898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mouse/human chimeric monoclonal antibody cA2 neutralizes TNF in vitro and protects transgenic mice from cachexia and TNF lethality in vivo.
    Siegel SA; Shealy DJ; Nakada MT; Le J; Woulfe DS; Probert L; Kollias G; Ghrayeb J; Vilcek J; Daddona PE
    Cytokine; 1995 Jan; 7(1):15-25. PubMed ID: 7538333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of tumor necrosis factor and lymphotoxin on peripheral lymphoid tissue development.
    Ettinger R; Mebius R; Browning JL; Michie SA; van Tuijl S; Kraal G; van Ewijk W; McDevitt HO
    Int Immunol; 1998 Jun; 10(6):727-41. PubMed ID: 9678753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble TNFR II/IgG1 Fc fusion protein treatment in the LPS-mediated septic shock of rats.
    Guo Z; Wang S; Jiao Q; Xu M; Xu Z
    Biomed Pharmacother; 2009 Aug; 63(7):537-42. PubMed ID: 18848768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-1-anti-trypsin-Fc fusion protein ameliorates gouty arthritis by reducing release and extracellular processing of IL-1β and by the induction of endogenous IL-1Ra.
    Joosten LA; Crişan TO; Azam T; Cleophas MC; Koenders MI; van de Veerdonk FL; Netea MG; Kim S; Dinarello CA
    Ann Rheum Dis; 2016 Jun; 75(6):1219-27. PubMed ID: 26174021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein.
    Moreland LW; Baumgartner SW; Schiff MH; Tindall EA; Fleischmann RM; Weaver AL; Ettlinger RE; Cohen S; Koopman WJ; Mohler K; Widmer MB; Blosch CM
    N Engl J Med; 1997 Jul; 337(3):141-7. PubMed ID: 9219699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNF-alpha blockade by a dimeric TNF type I receptor molecule selectively inhibits adaptive immune responses.
    Colagiovanni DB; Suniga MA; Frazier JL; Edwards CK; Fleshner M; McCay JA; White KL; Shopp GM
    Immunopharmacol Immunotoxicol; 2000 Nov; 22(4):627-51. PubMed ID: 11105778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNF plays an essential role in tumor regression after adoptive transfer of perforin/IFN-gamma double knockout effector T cells.
    Poehlein CH; Hu HM; Yamada J; Assmann I; Alvord WG; Urba WJ; Fox BA
    J Immunol; 2003 Feb; 170(4):2004-13. PubMed ID: 12574370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The locus of tumor necrosis factor-alpha action in lung inflammation.
    Smith S; Skerrett SJ; Chi EY; Jonas M; Mohler K; Wilson CB
    Am J Respir Cell Mol Biol; 1998 Dec; 19(6):881-91. PubMed ID: 9843922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction and preclinical characterization of Fc-mGITRL for the immunotherapy of cancer.
    Hu P; Arias RS; Sadun RE; Nien YC; Zhang N; Sabzevari H; Lutsiak ME; Khawli LA; Epstein AL
    Clin Cancer Res; 2008 Jan; 14(2):579-88. PubMed ID: 18223234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor-alpha inhibits collagen alpha1(I) gene expression and wound healing in a murine model of cachexia.
    Buck M; Houglum K; Chojkier M
    Am J Pathol; 1996 Jul; 149(1):195-204. PubMed ID: 8686743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.